摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-(2-acetyl-3-oxo-1-phenylbutyl)acetamide | 195969-43-8

中文名称
——
中文别名
——
英文名称
N-(2-acetyl-3-oxo-1-phenylbutyl)acetamide
英文别名
——
N-(2-acetyl-3-oxo-1-phenylbutyl)acetamide化学式
CAS
195969-43-8
化学式
C14H17NO3
mdl
——
分子量
247.294
InChiKey
IOXVORSURGWLGA-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    0.7
  • 重原子数:
    18
  • 可旋转键数:
    5
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.36
  • 拓扑面积:
    63.2
  • 氢给体数:
    1
  • 氢受体数:
    3

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    N-(2-acetyl-3-oxo-1-phenylbutyl)acetamide 作用下, 以 乙醇 为溶剂, 反应 1.0h, 以66%的产率得到N-[(3,5-dimethyl-1H-pyrazol-4-yl)(phenyl)methyl]acetamide
    参考文献:
    名称:
    N-(α-Amidoalkyl)benzotriazole-mediated synthesis of β′-amido β-diketones: a general synthetic protocol for N-[β-(3,5-di and 1,3,5-trisubstituted pyrazol-4-yl)alkyl] amides
    摘要:
    Various beta '-amido-beta-diketones were first synthesized with N-(alpha-amidoalkyl)benzotriazole-mediated amidoalkylation of 1,3-diketones in moderate yields. These intermediates undergo rapid condensation with hydrazines to give the corresponding N-[beta-(3,5-di and 1,3,5-trisubstituted pyrazol-4-yl)alkyl]amides. (C) 2008 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.tet.2008.10.047
  • 作为产物:
    描述:
    N-(1-benzotriazoyl-1-phenylmethyl)acetamide乙酰丙酮potassium tert-butylate 作用下, 以 二甲基亚砜 为溶剂, 反应 8.67h, 以89%的产率得到N-(2-acetyl-3-oxo-1-phenylbutyl)acetamide
    参考文献:
    名称:
    N-(α-Amidoalkyl)benzotriazole-mediated synthesis of β′-amido β-diketones: a general synthetic protocol for N-[β-(3,5-di and 1,3,5-trisubstituted pyrazol-4-yl)alkyl] amides
    摘要:
    Various beta '-amido-beta-diketones were first synthesized with N-(alpha-amidoalkyl)benzotriazole-mediated amidoalkylation of 1,3-diketones in moderate yields. These intermediates undergo rapid condensation with hydrazines to give the corresponding N-[beta-(3,5-di and 1,3,5-trisubstituted pyrazol-4-yl)alkyl]amides. (C) 2008 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.tet.2008.10.047
点击查看最新优质反应信息

文献信息

  • Facile and diastereoselective synthesis of β-acetamido ketones and keto esters via direct Mannich-type reaction
    作者:Hui Mao、Jieping Wan、Yuanjiang Pan
    DOI:10.1016/j.tet.2008.11.071
    日期:2009.1
    A Mannich-type three-component reaction involving aldehydes, acetamide, and enolizable ketones or β-keto esters for the preparation of β-acetamido carbonyl compounds in the presence of TMSCl is described. This newly developed protocol is operationally convenient, widely applicable, and highly diastereoselective.
    描述了用于在TMCSC1存在下制备β-乙酰基羰基化合物的涉及醛,乙酰胺和可烯醇化的酮或β-酮酯的曼尼希型三组分反应。该新开发的协议操作方便,适用范围广且具有非对映选择性。
  • Mannich Curcuminoids as Potent Anticancer Agents
    作者:Márió Gyuris、László Hackler、Lajos I. Nagy、Róbert Alföldi、Eszter Rédei、Annamária Marton、Tibor Vellai、Nóra Faragó、Béla Ózsvári、Anasztázia Hetényi、Gábor K. Tóth、Péter Sipos、Iván Kanizsai、László G. Puskás
    DOI:10.1002/ardp.201700005
    日期:2017.7
    A series of novel curcuminoids were synthesised for the first time via a Mannich‐3CR/organocatalysed Claisen–Schmidt condensation sequence. Structure–activity relationship (SAR) studies were performed by applying viability assays and holographic microscopic imaging to these curcumin analogues for anti‐proliferative activity against A549 and H1975 lung adenocarcinoma cells. The TNFα‐induced NF‐κB inhibition
    通过 Mannich-3CR/有机催化的 Claisen-Schmidt 缩合序列,首次合成了一系列新型姜黄素。通过对这些姜黄素类似物应用活力测定和全息显微成像,对 A549 和 H1975 肺腺癌细胞具有抗增殖活性,进行构效关系 (SAR) 研究。TNFα 诱导的 NF-κB 抑制和自噬诱导作用与类似物的细胞毒性潜力密切相关。当在 A549 异种移植模型中以最大耐受剂量的六分之一将最有效的类似物 44 添加到脂质体中时,观察到对肿瘤生长的显着抑制。这些曼尼希姜黄素的新活性谱需要进一步的临床前研究。
  • Bismuth(III) Oxychloride Procatalyst Based One-Pot Multicomponent Synthesis of β′-Acetamido-β-dicarbonyl Compounds with Special Reference to <i>pref</i>-β′-Acetamido-β-oxo Esters
    作者:Rina Ghosh、Swarupananda Maiti、Soumen Ghosh、Alok Mukherjee
    DOI:10.1055/s-2006-958955
    日期:2007.1
    Bismuth(III) chloride generated in situ from the procatalyst bismuth(III) oxychloride and acetyl chloride efficiently catalyzes the one-pot synthesis of β′-acetamido-β-dicarbonyl compounds from aldehydes, enolizable β-diketones, or β-oxo esters and acetyl chloride in acetonitrile solution and under solvent-free conditions at room temperature; in the case of the β-oxo ester derived products, these are obtained with moderate to excellent dia­stereoselectivity in favor of the pref-isomer. X-ray crystallographic analysis of one pref-β′-acetamido-β-oxo ester exhibits C-H···O and N-H···O intermolecular interactions in the three-dimensional supramolecular assembly.
    由原催化剂氧化铋(III)乙酰氯原位生成的氯化铋(III) 有效催化从醛、烯醇化β-二酮或β-氧代酯和β-氧代酯中一锅法合成β′-乙酰基-β-二羰基化合物。乙酰氯乙腈溶液,在无溶剂条件下,室温;就β-氧代酯衍生产品而言,这些产品具有中等至优异的非对映选择性,有利于预异构体。一种预-β′-乙酰基-β-氧代酯的X射线晶体学分析显示了三维超分子组装体中的C-H…O和N-H…O分子间相互作用。
  • A Modified and Green Procedure for the Synthesis of<i>β</i>-Amido Ketones Using a Br?nsted-Acidic Ionic Liquid as Novel and Reusable Catalyst
    作者:Abolghasem Davoodnia、Majid M. Heravi、Leila Rezaei-Daghigh、Niloofar Tavakoli-Hoseini
    DOI:10.1002/cjoc.201090091
    日期:2010.1
    and improved method for the synthesis of β‐amido ketones through one‐pot multi‐component reaction of an enolizable ketone, aryl aldehyde, acetonitrile or benzonitrile in the presence of trimethylsilyl chloride using 3‐methyl‐1‐(4‐sulfonic acid)butylimidazolium hydrogen sulfate [(CH2)4SO3HMIM][HSO4], a Br?nsted‐acidic ionic liquid, as an effective and recyclable catalyst is described. The present methodology
    在三甲基氯硅烷存在下,使用3-甲基-1-(4-磺酸)在三甲基甲硅烷的存在下,通过可烯化的酮,芳基醛,乙腈苄腈的单锅多组分反应,合成绿色改进的β-酰胺基酮的方法介绍了一种布朗斯台德酸性离子液体,即有效的可回收催化剂)-丁基咪唑硫酸氢盐[(CH 2)4 SO 3 HMIM] [HSO 4 ]。本方法具有许多优点,例如操作简单,易于操作,相对较短的反应时间以及良好的收率。
  • [EN] NOVEL MEDICINAL COMPOUNDS<br/>[FR] NOUVEAUX COMPOSÉS MÉDICAUX
    申请人:AVIDIN KUTATO FEJLESZTOE ES KERESKEDELMI KORLATOLT
    公开号:WO2013041895A1
    公开(公告)日:2013-03-28
    The invention relates to novel compounds of general formula (I), and their preparation, pharmaceutical preparations containing compounds of general formula (I), and the use of these compounds in therapeutic procedures. The invention also relates to compounds of general formula (VI), which can be used as intermediates in the processes for the preparation of compounds of general formula (I).
    该发明涉及一般式(I)的新化合物,以及它们的制备、含有一般式(I)化合物的药物制剂,以及这些化合物在治疗程序中的使用。该发明还涉及一般式(VI)的化合物,可用作制备一般式(I)化合物的过程中的中间体。
查看更多